Pravastatin Sodium 80 mg tablets recalled for manufacturing deviations
Accord Healthcare is recalling Pravastatin Sodium 80 mg tablets due to manufacturing process deviations discovered during an FDA inspection. The recall affects approximately 1,970 bottles distributed in the United States, Puerto Rico, and Canada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall without reported illnesses, injuries, or hospitalizations. The hazard—manufacturing process deviations identified during an FDA inspection—is regulatory and theoretical rather than manifested in patient harm. Per the rubric, theoretical hazards without reported illness score at most 3 (High).
Plain-English summary
Accord Healthcare, Inc. is recalling Pravastatin Sodium 80 mg tablets USP (NDC 16729-011-15, UPC 316729011150) in 90-count bottles. The product was manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India.
The recall was initiated following an FDA inspection that identified Current Good Manufacturing Practice (CGMP) deviations. These deviations represent failures to maintain proper quality standards and controls during drug manufacturing.
The affected batch is R2201233 with an expiration date of 4/30/2024. Approximately 1,970 bottles were distributed throughout the United States, Puerto Rico, and Canada.
Patients with Pravastatin Sodium from the affected batch should contact their pharmacy or healthcare provider to verify whether their medication is from the recalled batch. Check the NDC number (16729-011-15) and batch/expiration date printed on the bottle.
The recalled product
- Product
- PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batches: R2201233
- Exp. Date 4/30/2024
UPCs (1)
- 316729011150
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · PRAVASTATIN SODIUM
- ModerateFDA Recalls Pravastatin Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- ModerateDrug Recall: Pravastatin Sodium Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateFDA recalls Glenmark Pravastatin Sodium tablets for manufacturing deviations
FDA (Drugs) · 2025-04-16
- HighPravastatin Sodium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-07-24
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27